Skip to main content

Peer Review reports

From: Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a non-interventional observation study

Original Submission
3 May 2019 Submitted Original manuscript
23 Aug 2019 Author responded Author comments - Semjon Willier
23 Jul 2019 Reviewed Reviewer Report - Luigi Celio
25 Jul 2019 Reviewed Reviewer Report - Andrea Orsey
Resubmission - Version 2
23 Aug 2019 Submitted Manuscript version 2
27 Sep 2019 Author responded Author comments - Semjon Willier
16 Sep 2019 Reviewed Reviewer Report - Luigi Celio
18 Sep 2019 Reviewed Reviewer Report - Andrea Orsey
Resubmission - Version 3
27 Sep 2019 Submitted Manuscript version 3
8 Oct 2019 Author responded Author comments - Semjon Willier
Resubmission - Version 4
8 Oct 2019 Submitted Manuscript version 4
9 Oct 2019 Author responded Author comments - Semjon Willier
Resubmission - Version 5
9 Oct 2019 Submitted Manuscript version 5
Publishing
10 Oct 2019 Editorially accepted
15 Nov 2019 Article published 10.1186/s12885-019-6252-6

You can find further information about peer review here.

Back to article page